Northwest Investment Counselors’s Integra LifeSciences IART Stock Holding History

Northwest Investment Counselors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$73K	Buy	+4,020	New	+$93.2K	0.02%	207
2024 Q2	–	Sell	-4,020	Closed	-$143K	–	311
2024 Q1	$143K	Buy	+4,020	New	+$161K	0.03%	157
2023 Q4	–	Sell	-4,220	Closed	-$161K	–	313
2023 Q3	$161K	Sell	4,220 -160	-4%	-$6.73K	0.05%	155
2023 Q2	$180K	Hold	4,380	–	–	0.05%	152
2023 Q1	$251K	Hold	4,380	–	–	0.07%	140
2022 Q4	$246K	Hold	4,380	–	–	0.07%	144
2022 Q3	$186K	Hold	4,380	–	–	0.06%	147
2022 Q2	$237K	Hold	4,380	–	–	0.07%	135
2022 Q1	$281K	Hold	4,380	–	–	0.07%	134
2021 Q4	$293K	Hold	4,380	–	–	0.07%	132
2021 Q3	$300K	Hold	4,380	–	–	0.08%	127
2021 Q2	$299K	Hold	4,380	–	–	0.08%	128
2021 Q1	$303K	Hold	4,380	–	–	0.09%	127
2020 Q4	$284K	Hold	4,380	–	–	0.09%	130
2020 Q3	$207K	Hold	4,380	–	–	0.07%	132
2020 Q2	$206K	Buy	+4,380	New	+$215K	0.08%	131
2020 Q1	–	Sell	-4,380	Closed	-$255K	–	135
2019 Q4	$255K	Hold	4,380	–	–	0.09%	135
2019 Q3	$263K	Hold	4,380	–	–	0.09%	131
2019 Q2	$245K	Hold	4,380	–	–	0.09%	135
2019 Q1	$244K	Sell	4,380 -2,000	-31%	-$102K	0.09%	134
2018 Q4	$288K	Hold	6,380	–	–	0.13%	128
2018 Q3	$420K	Sell	6,380 -700	-10%	-$43.5K	0.16%	117
2018 Q2	$456K	Sell	7,080 -100	-1%	-$6.19K	0.18%	113
2018 Q1	$397K	Sell	7,180 -550	-7%	-$28.8K	0.17%	117
2017 Q4	$370K	Hold	7,730	–	–	0.15%	122
2017 Q3	$390K	Sell	7,730 -150	-2%	-$7.7K	0.17%	110
2017 Q2	$430K	Hold	7,880	–	–	0.19%	104
2017 Q1	$332K	Hold	7,880	–	–	0.16%	110
2016 Q4	$338K	Sell	7,880 -630	-7%	-$25.6K	0.17%	109
2016 Q3	$351K	Hold	8,510	–	–	0.18%	109
2016 Q2	$339K	Sell	8,510 -16	-0.2%	-$576	0.18%	108
2016 Q1	$287K	Sell	8,526 -400	-4%	-$12.5K	0.16%	112
2015 Q4	$303K	Sell	8,926 -760	-8%	-$23.8K	0.19%	107
2015 Q3	$288K	Sell	9,686 -2,397	-20%	-$75K	0.19%	99
2015 Q2	$333K	Sell	12,083 -206	-2%	-$5.49K	0.21%	99
2015 Q1	$310K	Sell	12,289 -122	-1%	-$2.88K	0.19%	101
2014 Q4	$275K	Sell	12,411 -186	-1%	-$3.77K	0.18%	100
2014 Q3	$256K	Buy	12,597 +42	+0.3%	+$836	0.17%	96
2014 Q2	$242K	Sell	12,555 -8	-0.1%	-$149	0.16%	96
2014 Q1	$236K	Buy	12,563 +8	+0.1%	+$154	0.16%	101
2013 Q4	$245K	Hold	12,555	–	–	0.17%	98
2013 Q3	$207K	Sell	12,555 -1,292	-9%	-$20.7K	0.16%	102
2013 Q2	$207K	Buy	+13,847	New	+$203K	0.17%	98

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northwest Investment Counselors's IART Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Integra LifeSciences (IART) in Q3 2024: 4,020 shares worth $73K. The stake represents 0.02% of the portfolio and ranks #207 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in IART as recently as Q1 2024.

Northwest Investment Counselors first reported a position in IART in Q2 2013 and has held it in 43 quarters since. The position peaked at $456K in Q2 2018. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Northwest Investment Counselors held 4,020 shares of Integra LifeSciences worth $73K as of Q3 2024.
Integra LifeSciences was a new Northwest Investment Counselors position in Q3 2024.
Integra LifeSciences made up 0.02% of Northwest Investment Counselors's portfolio in Q3 2024, its #207 holding.
Northwest Investment Counselors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 43 quarters since.
Northwest Investment Counselors's Integra LifeSciences position peaked at $456K in Q2 2018.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.